TELA Bio, Inc. Stock-Based Compensation
TELA Bio, Inc. (TELA) reported Stock-Based Compensation of $1.43 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-11
- TELA Bio, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $613.00K, a 37.77% decline year-over-year.
- TELA Bio, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $816.00K, a 21.84% decline year-over-year.
- TELA Bio, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $812.00K, a 25.44% decline year-over-year.
- TELA Bio, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $955.00K, a 11.66% decline year-over-year.
- TELA Bio, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $3.80M, a 12.98% decline from fiscal 2024.
- TELA Bio, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $4.36M, a 13.31% decline from fiscal 2023.
- TELA Bio, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $5.03M, a 26.15% increase from fiscal 2022.
- TELA Bio, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $3.99M, a 8.96% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $613.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $1.43M 10-Q · filed 2026-08-11 | $2.24M derived: sum of 3 quarters · filed 2026-08-11 | $3.20M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $816.00K 10-Q · filed 2026-05-13 | $1.63M derived: sum of 2 quarters · filed 2026-05-13 | $2.58M derived: sum of 3 quarters · filed 2026-05-13 | $3.57M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $812.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.77M derived: sum of 2 quarters · filed 2026-03-25 | $2.75M derived: sum of 3 quarters · filed 2026-08-11 | $3.80M 10-K · filed 2026-03-25 |
| 2025-09-30 | $955.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.94M derived: sum of 2 quarters · filed 2026-08-11 | $2.98M 10-Q · filed 2025-11-14 | $4.07M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $985.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $2.03M 10-Q · filed 2026-08-11 | $3.12M derived: sum of 3 quarters · filed 2026-08-11 | $4.20M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $1.04M 10-Q · filed 2026-05-13 | $2.13M derived: sum of 2 quarters · filed 2026-05-13 | $3.21M derived: sum of 3 quarters · filed 2026-05-13 | $4.30M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $2.17M derived: sum of 2 quarters · filed 2026-03-25 | $3.26M derived: sum of 3 quarters · filed 2026-03-25 | $4.36M 10-K · filed 2026-03-25 |
| 2024-09-30 | $1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $2.17M derived: sum of 2 quarters · filed 2025-11-14 | $3.27M 10-Q · filed 2025-11-14 | $4.51M derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-06-30 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $2.19M 10-Q · filed 2025-08-11 | $3.43M derived: sum of 3 quarters · filed 2026-03-25 | $4.80M derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-03-31 | $1.10M 10-Q · filed 2025-05-08 | $2.34M derived: sum of 2 quarters · filed 2026-03-25 | $3.71M derived: sum of 3 quarters · filed 2026-03-25 | $5.01M derived: sum of 4 quarters · filed 2026-03-25 |
| 2023-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $2.61M derived: sum of 2 quarters · filed 2026-03-25 | $3.90M derived: sum of 3 quarters · filed 2026-03-25 | $5.03M 10-K · filed 2026-03-25 |
| 2023-09-30 | $1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $2.66M derived: sum of 2 quarters · filed 2024-11-08 | $3.79M 10-Q · filed 2024-11-08 | $4.83M derived: sum of 4 quarters · filed 2025-03-21 |
| 2023-06-30 | $1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $2.42M 10-Q · filed 2024-08-13 | $3.46M derived: sum of 3 quarters · filed 2025-03-21 | $4.49M derived: sum of 4 quarters · filed 2025-03-21 |
| 2023-03-31 | $1.13M 10-Q · filed 2024-05-10 | $2.17M derived: sum of 2 quarters · filed 2025-03-21 | $3.19M derived: sum of 3 quarters · filed 2025-03-21 | $4.22M derived: sum of 4 quarters · filed 2025-03-21 |
| 2022-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $2.07M derived: sum of 2 quarters · filed 2025-03-21 | $3.09M derived: sum of 3 quarters · filed 2025-03-21 | $3.99M 10-K · filed 2025-03-21 |
| 2022-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $2.05M derived: sum of 2 quarters · filed 2023-11-13 | $2.95M 10-Q · filed 2023-11-13 | $3.77M derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-06-30 | $1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $1.92M 10-Q · filed 2023-08-10 | $2.75M derived: sum of 3 quarters · filed 2024-03-22 | $3.48M derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-03-31 | $901.00K 10-Q · filed 2023-05-11 | $1.72M derived: sum of 2 quarters · filed 2024-03-22 | $2.46M derived: sum of 3 quarters · filed 2024-03-22 | $3.87M derived: sum of 4 quarters · filed 2024-03-22 |
| 2021-12-31 | $822.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $1.55M derived: sum of 2 quarters · filed 2024-03-22 | $2.97M derived: sum of 3 quarters · filed 2024-03-22 | $3.66M 10-K · filed 2024-03-22 |
| 2021-09-30 | $733.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $2.15M derived: sum of 2 quarters · filed 2022-11-10 | $2.84M 10-Q · filed 2022-11-10 | $3.41M derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-06-30 | $1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $2.11M 10-Q · filed 2022-08-11 | $2.68M derived: sum of 3 quarters · filed 2023-03-23 | $3.22M derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-03-31 | $694.00K 10-Q · filed 2022-05-11 | $1.27M derived: sum of 2 quarters · filed 2023-03-23 | $1.81M derived: sum of 3 quarters · filed 2023-03-23 | $2.30M derived: sum of 4 quarters · filed 2023-03-23 |
| 2020-12-31 | $572.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $1.11M derived: sum of 2 quarters · filed 2023-03-23 | $1.61M derived: sum of 3 quarters · filed 2023-03-23 | $2.06M 10-K · filed 2023-03-23 |
| 2020-09-30 | $543.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.04M derived: sum of 2 quarters · filed 2021-11-12 | $1.49M 10-Q · filed 2021-11-12 | $1.76M derived: sum of 4 quarters · filed 2022-03-23 |
| 2020-06-30 | $494.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $943.00K 10-Q · filed 2021-08-12 | $1.22M derived: sum of 3 quarters · filed 2022-03-23 | $1.28M derived: sum of 4 quarters · filed 2022-03-23 |
| 2020-03-31 | $449.00K 10-Q · filed 2021-05-14 | $723.00K derived: sum of 2 quarters · filed 2022-03-23 | $787.00K derived: sum of 3 quarters · filed 2022-03-23 | $846.00K derived: sum of 4 quarters · filed 2022-03-23 |
| 2019-12-31 | $274.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $338.00K derived: sum of 2 quarters · filed 2022-03-23 | $397.00K derived: sum of 3 quarters · filed 2022-03-23 | $457.00K 10-K · filed 2022-03-23 |
| 2019-09-30 | $64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $123.00K derived: sum of 2 quarters · filed 2020-11-12 | $183.00K 10-Q · filed 2020-11-12 | $230.00K derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-06-30 | $59.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $119.00K 10-Q · filed 2020-08-13 | $166.00K derived: sum of 3 quarters · filed 2021-03-25 | |
| 2019-03-31 | $60.00K 10-Q · filed 2020-05-15 | $107.00K derived: sum of 2 quarters · filed 2021-03-25 | ||
| 2018-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $216.00K 10-K · filed 2021-03-25 | ||
| 2018-09-30 | $169.00K 10-Q · filed 2019-12-18 | |||
| 2017-12-31 | $197.00K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |